AXSOME THERAPEUTICS INC. - COMMON STOCK
121.91
14-March-25 16:45:00
15 minutes delayed
Stocks
+0.26
+0.21%
Today's range
120.52 - 123.47
ISIN
N/A
Source
NASDAQ
-
27 Feb 2023 07:00:00 By Nasdaq GlobeNewswire
-
22 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the SVB Securities Global Biopharma Conference
07 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27
31 Jan 2023 07:00:00 By Nasdaq GlobeNewswire
-
07 Dec 2022 07:00:00 By Nasdaq GlobeNewswire
-
28 Nov 2022 06:35:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference
23 Nov 2022 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
09 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
07 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today
27 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Third Quarter 2022 Financial Results on November 7, 2022
21 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
20 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022
10 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
29 Sep 2022 07:28:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
21 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit
14 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Initiates ADVANCE-2 Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
08 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06 Sep 2022 07:00:01 By Nasdaq GlobeNewswire